Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2005

01-12-2005 | Brief Report

New strains of community-acquired methicillin-resistant Staphylococcus aureus with Panton–Valentine leukocidin causing an outbreak of severe soft tissue infection in a football team

Authors: M. Müller-Premru, B. Strommenger, N. Alikadic, W. Witte, A. W. Friedrich, K. Seme, N. Svent Kucina, D. Smrke, V. Spik, M. Gubina

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2005

Login to get access

Excerpt

A new category of methicillin-resistant Staphylococcus aureus (MRSA), designated community-acquired MRSA (CA-MRSA), has been noted increasingly in the community in the past 14 years [1]. CA-MRSA strains have different genetic backgrounds than hospital-acquired MRSA, as evidenced by pulsed-field gel electrophoresis (PFGE) patterns, and thus do not descend from nosocomial strains. They also carry a novel staphylococcal cassette chromosome (SCC) mec type IV element, which is differentiated from the hospital-acquired MRSA SCCmec types I-III by its smaller size and the absence of non-ß-lactam genetic resistance determinants. In addition, CA-MRSA strains replicate more rapidly than hospital-acquired MRSA strains, they have a better ability to colonize humans, and they possess genes for different toxins [2]. Major risk factors for CA-MRSA colonization, as recognized by Ellis et al. [3], are treatment with systemic antibiotics and skin trauma. The strains producing Panton–Valentine leukocidin cause furunculosis and severe necrotic hemorrhagic pneumonia in otherwise healthy individuals [3, 4]. Outbreaks have been described in day-care and athletic settings. Sport teams are especially vulnerable to infections with these strains because of frequent skin trauma and close contact of team members [4]. In order to detect outbreaks of new CA-MRSA, molecular typing [58] should be performed and virulence genes detected [9]. Reported here is an outbreak of severe soft tissue infection affecting a football team, which was caused by a new strain of community-acquired methicillin-resistant Staphylococcus aureus carrying the Panton–Valentine leukocidin gene. …
Literature
1.
go back to reference Wandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984PubMed Wandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984PubMed
2.
go back to reference Daum RS, Teruyo I, Hiramatsu K, Hussain F, Mongkolrattanothai K, Jamklang M, Boyle-Vavra S (2002) A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 186:1344–1347CrossRefPubMed Daum RS, Teruyo I, Hiramatsu K, Hussain F, Mongkolrattanothai K, Jamklang M, Boyle-Vavra S (2002) A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 186:1344–1347CrossRefPubMed
3.
go back to reference Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK (2004) Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 39:971–979CrossRefPubMed Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK (2004) Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 39:971–979CrossRefPubMed
4.
go back to reference Lina G, Piemont Y, Godail-Gamot F, le Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128–1132CrossRefPubMed Lina G, Piemont Y, Godail-Gamot F, le Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128–1132CrossRefPubMed
5.
go back to reference Fey PD, Said-Salim B, Rupp ME, Hinrichs SH, Boxrud DJ, Davis CC, Kreiswirth BN, Schlievert PM (2003) Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:196–203CrossRefPubMed Fey PD, Said-Salim B, Rupp ME, Hinrichs SH, Boxrud DJ, Davis CC, Kreiswirth BN, Schlievert PM (2003) Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:196–203CrossRefPubMed
6.
go back to reference Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239PubMed Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239PubMed
7.
go back to reference Harmsen D, Claus H, Witte W, Rothgaenger J, Claus H, Turnwald D, Vogel U (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41:5442–5448CrossRefPubMed Harmsen D, Claus H, Witte W, Rothgaenger J, Claus H, Turnwald D, Vogel U (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41:5442–5448CrossRefPubMed
8.
go back to reference Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). PNAS 99:7687–7692CrossRefPubMed Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). PNAS 99:7687–7692CrossRefPubMed
9.
go back to reference Prevost G, Couppie P, Prevost P, Gayet S, Petiau P, Cribier B (1995) Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 42:237–245PubMedCrossRef Prevost G, Couppie P, Prevost P, Gayet S, Petiau P, Cribier B (1995) Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 42:237–245PubMedCrossRef
10.
go back to reference National Committee for Clinical Laboratory Standards (2003) Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Approved standard M100. NCCLS, Villanova, PA National Committee for Clinical Laboratory Standards (2003) Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Approved standard M100. NCCLS, Villanova, PA
11.
go back to reference Reischl U, Linde HJ, Metz M, Leppmeier B, Lehn N (2000) Rapid identification of methicillin-resistant Staphylococcus aureus and simultaneous species confirmation using real-time fluorescence PCR. J Clin Microbiol 38:2429–2433PubMed Reischl U, Linde HJ, Metz M, Leppmeier B, Lehn N (2000) Rapid identification of methicillin-resistant Staphylococcus aureus and simultaneous species confirmation using real-time fluorescence PCR. J Clin Microbiol 38:2429–2433PubMed
12.
go back to reference Witte W, Braulke C, Cuny C, Strommenger B, Werner W, Heuck D, Jappe U, Wendt C, Linde H-J, Harmsen D (2005) Emergence of methicillin-resistant Staphylococcus aureus with Panton–Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis 24:1–5CrossRefPubMed Witte W, Braulke C, Cuny C, Strommenger B, Werner W, Heuck D, Jappe U, Wendt C, Linde H-J, Harmsen D (2005) Emergence of methicillin-resistant Staphylococcus aureus with Panton–Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis 24:1–5CrossRefPubMed
13.
go back to reference Kazakova S, Hageman JC, Matawa M, Srinivasan A, Phelan L, Garfinkel B, Boo T, McAllister S, Anderson J, Jensen B, Dodson D, Lonsway D, McDougal L, Arduino M, Fraser VJ, Killgore G, Tenover FC, Cody S, Jernigan DB (2005) A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352:468–475CrossRefPubMed Kazakova S, Hageman JC, Matawa M, Srinivasan A, Phelan L, Garfinkel B, Boo T, McAllister S, Anderson J, Jensen B, Dodson D, Lonsway D, McDougal L, Arduino M, Fraser VJ, Killgore G, Tenover FC, Cody S, Jernigan DB (2005) A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352:468–475CrossRefPubMed
14.
go back to reference Hanssen AM, Fossum A, Mikalsen J, Halvorsen DS, Bukholm G, Ericson Sollid JU (2005) Dissemination of community-acquired methicillin-resistant Staphylococcus aureus clones in northern Norway: sequence types 8 and 80 predominate. J Clin Microbiol 43:2118–2124CrossRefPubMed Hanssen AM, Fossum A, Mikalsen J, Halvorsen DS, Bukholm G, Ericson Sollid JU (2005) Dissemination of community-acquired methicillin-resistant Staphylococcus aureus clones in northern Norway: sequence types 8 and 80 predominate. J Clin Microbiol 43:2118–2124CrossRefPubMed
Metadata
Title
New strains of community-acquired methicillin-resistant Staphylococcus aureus with Panton–Valentine leukocidin causing an outbreak of severe soft tissue infection in a football team
Authors
M. Müller-Premru
B. Strommenger
N. Alikadic
W. Witte
A. W. Friedrich
K. Seme
N. Svent Kucina
D. Smrke
V. Spik
M. Gubina
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-005-0048-0

Other articles of this Issue 12/2005

European Journal of Clinical Microbiology & Infectious Diseases 12/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine